In vitro study of BSA gel/polyelectrolite complexes core shell microcapsules encapsulating doxorubicin for antitumoral targeted treatment

Abstract

The aim of this study is to develop core shell microcapsules of bovine serum albumin (BSA) gel with a complex polyelectrolite multilayer shell of natural polysaccharides with opposite charges, pectin (P), chitosan (Chi), and hyaluronic acid (HA) respectively, encapsulating Doxorubicin (Dox) as a carrier for targeted anti-tumoral treatment of hepatic cell carcinoma (HCC). A sacrificial CaCO3 template method was used in order to obtain microcapsules with a BSA gel core and a layer-by-layer (Lbl) deposition technique of polyelectrolite complexes formed between P/Chi in the inner layers and HA/Chi in the outer shell layers. The preformed microcapsules, BSA gel/P/Chi/HA, noted as ms, have been applied for Dox encapsulation (ms-Dox). Dox encapsulation and release in different pH media were studied in order to elucidate the interactions between pH dependently charged species involved in the Dox loading/releasing processes. The structure characterization of ms/ms-Dox was evaluated by FTIR and UV-Vis spectroscopy, X-ray diffraction, thermal analy sis, optical microscopy, confocal laser scanning microscopy, and scanning electron microscopy. The in vitro study for citotoxicity assessment on normal and tumoral cells of both ms and ms-Dox was performed using mesenchymal stem cells (MSCs) and Hep2G HCC cell lines. Results of physical-chemical analyses confirm the successful encapsulation of Dox in ms, and the in vitro biological study recommends ms-Dox as a candidate for future in vivo research as a targeted anti-tumoral treatment modality applications.